NCT03848637View on ClinicalTrials.gov

The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-375

PHASE1UnknownINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

April 14, 2019

Primary Completion Date

April 24, 2019

Study Completion Date

May 1, 2019

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

CKD-375

Test drug

DRUG

D387

Reference drug

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT03848637 - The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-375 | Biotech Hunter | Biotech Hunter